Fecal Microbiota Transplantation & Diabetes Mellitus
Gut microbiota and type 2 diabetes mellitus.
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.
Microbiome and diabetes: Where are we now?
Research progress in the relationship between type 2 diabetes mellitus and intestinal flora.
Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Targeting gut microbiota as a possible therapy for diabetes.
IMPLICATION OF GUT MICROBIOTA IN DIABETES MELLITUS AND OBESITY.
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.
From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study.
Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis.
Insights into the role of the microbiome in obesity and type 2 diabetes.
Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Pancreatic Diseases and Microbiota: A Literature Review and Future Perspectives.
Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus.